Investigation of Safety, Tolerability and Bioavailability of NN9925 in Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 02 Mar 2017
At a glance
- Drugs NN 9925; NN 9925
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 29 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Aug 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 24 Mar 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.